# Outpatient care changes and associated mortality among Veterans with heart failure during the COVID-19 pandemic

## TL;DR

During the pandemic, Veterans with heart failure had fewer outpatient visits, and those who had in-person visits had lower mortality risk compared to those with no visits.

## Contribution

Quantified the impact of reduced in-person outpatient care and increased virtual visits on mortality in heart failure patients during the pandemic.

## Key findings

- Outpatient visits for heart failure patients decreased significantly during the pandemic despite increased use of virtual care.
- In-person visits were associated with the lowest mortality risk compared to video-only or telephone-only visits.
- The mortality risk was higher for patients with no outpatient visits compared to those who had any form of visit.

## Abstract

The mortality risk associated with loss of in-person outpatient visits or transition to virtual care in patients with heart failure (HF) during the COVID-19 pandemic is unknown.

Assess changes in outpatient HF care patterns and associated mortality.

Retrospective analysis of HF patients using national Veterans-Health-Administration (VHA) data. Among 509,511 HF patients who received VHA care, we compared mean monthly days-with-an-outpatient-visit from 2/2018–1/2020 (pre-COVID) versus 2/2020–1/2021 (COVID) using T-tests. In a subset of 321,439 patients with ≥1 VHA cardiology or primary-care visit in 2019, we related the presence and type of outpatient visit with mortality using Cox-Regression estimated hazard-ratios (HRs).

Despite a 2–3-fold increase in video-only visits and use of telephone visits to maintain access, the overall days with outpatient visits decreased from a monthly-average of 81.4 ± 6.1 in 2018–2019 and 81.0 ± 5.6 in 2019–2020, to 57.8 ± 11 days in 2020–2021 (P < 0.01 for both), per 100 Veterans. When compared to patients with no-visits during the study period, the adjusted-mortality risk was lowest for patients with at least one in-person (HR 0.42, 95%CI: 0.41–0.44), followed by video-only (HR 0.52, 95%CI: 0.50–0.55) and then telephone-only (HR 0.57, 95%CI: 0.54–0.60) visits (p = 0.14 for trend). Results remained similar when the analysis was repeated (without including telephone visits) for pre-COVID (2/2018–1/2020) periods.

Despite an increase in video and use of telephone visits during the COVID-19 pandemic, there was still a decrease in total outpatient visits for patients with HF. The presence and type of outpatient encounter was associated with the adjusted risk of mortality.